• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful topical treatment with ketoconazole for facial rashes refractory to dupilumab in patients with atopic dermatitis: case reports.

作者信息

Okiyama N, Nakamura Y, Ishitsuka Y, Inoue S, Kubota N, Saito A, Watanabe R, Fujisawa Y, Igawa K

机构信息

Department of Dermatology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.

Department of Dermatology, Dokkyo Medical University School of Medicine, Tochigi, Japan.

出版信息

J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e474-e476. doi: 10.1111/jdv.16383. Epub 2020 Jun 9.

DOI:10.1111/jdv.16383
PMID:32215964
Abstract
摘要

相似文献

1
Successful topical treatment with ketoconazole for facial rashes refractory to dupilumab in patients with atopic dermatitis: case reports.酮康唑局部治疗特应性皮炎患者中对度普利尤单抗难治的面部皮疹成功：病例报告
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e474-e476. doi: 10.1111/jdv.16383. Epub 2020 Jun 9.
2
Rosacea associated with dupilumab therapy.与度普利尤单抗治疗相关的酒渣鼻。
J Dermatolog Treat. 2021 Feb;32(1):114-116. doi: 10.1080/09546634.2019.1624683. Epub 2019 Jun 9.
3
Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next?2017 年批准用于治疗特应性皮炎后dupilumab 的新进展：有哪些新进展和下一步计划？
Curr Opin Allergy Clin Immunol. 2019 Aug;19(4):341-349. doi: 10.1097/ACI.0000000000000551.
4
Dupilumab reduces inflammation and restores the skin barrier in patients with atopic dermatitis.度普利尤单抗可减轻特应性皮炎患者的炎症并恢复皮肤屏障功能。
Allergy. 2021 Apr;76(4):1268-1270. doi: 10.1111/all.14664. Epub 2020 Dec 16.
5
Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study.使用度普利尤单抗治疗的重度特应性皮炎患者的体重增加：一项队列研究。
BMC Dermatol. 2020 Sep 22;20(1):8. doi: 10.1186/s12895-020-00103-0.
6
Dupilumab in the treatment of moderate-to-severe atopic dermatitis.度普利尤单抗治疗中重度特应性皮炎
Expert Rev Clin Immunol. 2017 Apr;13(4):301-310. doi: 10.1080/1744666X.2017.1292134. Epub 2017 Feb 15.
7
Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report.度普利尤单抗治疗对全身免疫抑制难治的重度特应性皮炎：病例报告
Einstein (Sao Paulo). 2019 Jul 10;17(4):eRC4599. doi: 10.31744/einstein_journal/2019RC4599.
8
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.度普利尤单抗联合外用皮质类固醇治疗中重度特应性皮炎的长期管理（LIBERTY AD CHRONOS）：一项为期 1 年、随机、双盲、安慰剂对照、3 期临床试验。
Lancet. 2017 Jun 10;389(10086):2287-2303. doi: 10.1016/S0140-6736(17)31191-1. Epub 2017 May 4.
9
Dupilumab therapy in a patient with atopic dermatitis and severe atopic keratoconjunctivitis.
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e281-e283. doi: 10.1111/jdv.16278. Epub 2020 Mar 6.
10
Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis.特应性皮炎患者的度普利尤单抗相关性结膜炎。
Cornea. 2020 Jun;39(6):784-786. doi: 10.1097/ICO.0000000000002262.

引用本文的文献

1
An unbiased tissue transcriptome analysis identifies potential markers for skin phenotypes and therapeutic responses in atopic dermatitis.一项无偏倚的组织转录组分析确定了特应性皮炎皮肤表型和治疗反应的潜在标志物。
Nat Commun. 2025 Jun 2;16(1):4981. doi: 10.1038/s41467-025-59340-x.
2
Fungal Head and Neck Dermatitis: Current Understanding and Management.真菌性头颈部皮炎：当前的认识和管理。
Clin Rev Allergy Immunol. 2024 Jun;66(3):363-375. doi: 10.1007/s12016-024-09000-7. Epub 2024 Jul 20.
3
Dupilumab-associated Facial Erythema Successfully Treated With Oral Ivermectin.
口服伊维菌素成功治疗度普利尤单抗相关的面部红斑
Dermatol Pract Concept. 2022 Oct 1;12(4):e2022184. doi: 10.5826/dpc.1204a184. eCollection 2022 Nov.
4
Dupilumab-Associated Head and Neck Dermatitis With Ocular Involvement in a Ten-Year-Old With Atopic Dermatitis: A Case Report and Review of the Literature.度普利尤单抗相关的头颈部皮炎伴眼部受累：一例10岁特应性皮炎患儿的病例报告及文献复习
Cureus. 2022 Jul 23;14(7):e27170. doi: 10.7759/cureus.27170. eCollection 2022 Jul.
5
Study of Hypersensitivity to in Patients with Atopic Dermatitis with Head and Neck Pattern: Is It Useful as a Biomarker and Therapeutic Indicator in These Patients?头颈部型特应性皮炎患者对[具体物质]超敏反应的研究：它能否作为这些患者的生物标志物和治疗指标？ （注：原文中“in Patients with Atopic Dermatitis with Head and Neck Pattern”里的“in”后面应该有具体物质，这里按照完整的翻译思路给出译文，需根据实际原文补充完整该物质）
Life (Basel). 2022 Feb 16;12(2):299. doi: 10.3390/life12020299.
6
A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis.度普利尤单抗治疗特应性皮炎的真实世界有效性和安全性文献综述。
JID Innov. 2021 Jul 30;1(3):100042. doi: 10.1016/j.xjidi.2021.100042. eCollection 2021 Sep.
7
Nomenclature and clinical phenotypes of atopic dermatitis.特应性皮炎的命名及临床表型
Ther Adv Chronic Dis. 2021 Mar 26;12:20406223211002979. doi: 10.1177/20406223211002979. eCollection 2021.